Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies-Reference-Cited by-同舟云学术

Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies

Published:2023-10 Issue: Volume:250 Page:108527
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Wang Qiyue,Xin Xiaofei,Dai Qihao,Sun Mengjuan,Chen Jinhua,Mostafavi Ebrahim,Shen Yan,Li Xueming

Funder

Natural Science Research of Jiangsu Higher Education Institutions of China

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference229 articles.

1. Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential;Agrahari;Advanced Drug Delivery Reviews,2019

2. Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the “Head Start” trials, 1991-2009;Altshuler;Bone Marrow Transplant.,2016

3. Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain;Anraku;Nature Communications,2017

4. Immunosuppression in Medulloblastoma: Insights into Cancer immunity and immunotherapy;Audi;Current Treatment Options in Oncology,2021

5. Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A Children’s oncology group study;Bagatell;Pediatric Blood & Cancer,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Treatment Resistance in Medulloblastoma: Underlying Mechanisms and Potential Strategies;Cancers;2024-06-18

2. FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis;The Journal of Pathology;2024-01-17